BGM (BGM Group) Research & Development: $1.42 Mil (TTM As of Mar. 2025)


BGM BGM Group Ltd BGM
53 GF Score
Price $0.33
GF Value $1.23
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is BGM Group Research & Development?

BGM Group BGM -3.12% 53 Research & Development is $1.42 Mil as of Mar. 2025. GuruFocus rates BGM with a GF Score™ of 53/100 and a GF Value™ of $1.23 (Possible Value Trap). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. BGM Group's Research & Development for the six months ended in Mar. 2025 was $0.53 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was $1.42 Mil.

BGM Group  (NAS:BGM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BGM Group Research & Development Related Terms

BGM Group Research & Development Historical Data

* Premium members only.

The historical data trend for BGM Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BGM Group Research & Development Chart

BGM Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Research & Development
Get a 7-Day Free Trial 0.00 0.00 1.22 0.57 1.36

BGM Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.30 0.47 0.89 0.53
BGM
53GF Score
BGM Group Ltd BGM
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BGM Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $1.42 Mil mean?
BGM Group (BGM) has a Research & Development of $1.42 Mil as of Mar. 2025. Research and development expense is the total cost for research and development activities. View historical data on BGM Group and its competitors.
Is BGM Group's Research & Development too high?
BGM Group's current Research & Development is $1.42 Mil. Overall, BGM Group has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BGM Group's Research & Development compare to INCR and SCYX?
BGM Group's Research & Development of $1.42 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on BGM Group and its competitors. BGM Group's current Research & Development is $1.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BGM Group stock overvalued right now?
Based on GuruFocus' analysis, BGM Group (BGM) is currently considered Possible Value Trap. The stock's GF Value™ is $1.23, compared to a current price of $0.33 — trading 73.3% below its estimated fair value. The current Research & Development is $1.42 Mil. BGM Group's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For BGM Group (BGM), the current Research & Development is $1.42 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BGM Group (BGM) Overvalued in 2026?

Based on GuruFocus' analysis, BGM Group stock appears to be undervalued. The current stock price of $0.33 is trading 73.3% below its estimated GF Value™ of $1.23. GuruFocus considers BGM Group to be Possible Value Trap.

Key valuation signals for BGM:

  • Research & Development: $1.42 Mil
  • GF Value™: $1.23 vs. price of $0.33 (73.3% below fair value)
  • GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the BGM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BGM Group Business Description

Address No. 152 Hongliang East 1st Street No. 1703, Tianfu New District, Chengdu, CHN, 610200
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
53GF Score

Get the complete analysis for BGM

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.33
Price
$1.23
GF Value